Regenerative medicine without the hype. Science without the spin.
DrRamon supports legitimate regenerative medicine and evaluates claims according to what the evidence actually demonstrates. Biological plausibility, clinical experience and controlled human evidence answer different questions.
What we look for
For consequential treatment claims, our standard is to identify the population, exact product or cell source, route, dose, comparator, outcomes and follow-up. A study of one intervention is not automatically evidence for another intervention with a similar name.
How claims are described
- Well supported: Applicable human evidence supports the specific claim, with study quality and limitations stated.
- Reasonable but requires qualification: A statement is defensible only with important limits on its meaning.
- Promising/investigational: A signal or rationale warrants further study; effectiveness is not established for routine use.
- Potentially misleading: The wording could suggest more than the evidence supports.
- Unsupported: Adequate support has not been found within the stated review. This does not prove impossibility.
- Outdated: Later evidence or a changed context materially alters the statement.
What does not establish efficacy
Testimonials illustrate individual experiences. Laboratory and animal findings provide a research rationale. Neither establishes the effectiveness of a treatment in humans. Statistical change within a treated group is not automatically superiority over a comparison group, and symptom relief does not by itself establish tissue regeneration.
Our publication standard
Substantial new or revised articles should explain uncertainty, adverse events, alternatives and the possibility of no benefit. They should link their sources and identify relevant commercial relationships. A review date is not a claim that every study ever published has been examined.
This standard guides ongoing revision of the archive. Older articles may not yet meet every element. Scientific conclusions take priority over commercial interests.
